Jorge Santos da Silva's most recent trade in MoonLake Immunotherapeutics - Ordinary Shares - Class A was a trade of 98,127 Class A ordinary shares, par value $0.0001 per share done at an average price of $18.4 . Disclosure was reported to the exchange on April 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.41 per share. | 10 Apr 2026 | 98,127 | 2,976,766 | - | 18.4 | 1,806,518 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.23 per share. | 10 Apr 2026 | 51,873 | 2,924,893 | - | 18.2 | 945,645 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 520,342 | 520,342 | - | - | Stock Option (Right to Buy) | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 196,316 | 0 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | 19 Dec 2025 | 196,316 | 3,074,893 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | 19 Dec 2025 | 5,836 | 0 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG | ||
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 08 Dec 2025 | 130,000 | 2,948,577 | - | 15.1 | 1,960,400 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 08 Dec 2025 | 70,000 | 2,878,577 | - | 14.5 | 1,014,300 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 95,763 | 3,078,577 | - | 0 | Class A ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 62,810 | 3,043,619 | - | 55 | 3,454,550 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Santos da Silva Jorge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 56,065 | 2,987,554 | - | 55 | 3,083,575 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.89 per share. | 27 Feb 2024 | 4,740 | 2,982,814 | - | 55.9 | 264,919 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Santos da Silva Jorge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.27 per share. | 21 Feb 2024 | 1,125 | 3,106,429 | - | 55.3 | 62,179 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.18 per share. | 15 Feb 2024 | 20,000 | 3,147,554 | - | 60.2 | 1,203,600 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.44 per share. | 15 Feb 2024 | 20,000 | 3,107,554 | - | 57.4 | 1,148,800 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Santos da Silva Jorge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 15 Feb 2024 | 20,000 | 3,127,554 | - | 60.2 | 1,203,000 | Class A ordinary shares, par value $0.0001 per share |